Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

MDG

Meridian Gold (MDG)

Meridian Gold
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:MDG
DataHoraFonteTítuloCódigoCompanhia
27/01/201406:23GlobeNewswireMedigene acquires Trianta ImmunotherapiesNYSE:MDGMeridian Gold
27/01/201406:22GlobeNewswireMedigene übernimmt Trianta ImmunotherapiesNYSE:MDGMeridian Gold
18/12/201304:30GlobeNewswireMedigene's drug Veregen® launched in Norway and SwedenNYSE:MDGMeridian Gold
18/12/201304:30GlobeNewswireMedigenes Medikament Veregen® kommt in Norwegen und Schweden auf den MarktNYSE:MDGMeridian Gold
13/12/201304:30GlobeNewswireMedigene Granted Additional Patent for RhuDex® for the Treatment of Autoimmune DiseasesNYSE:MDGMeridian Gold
13/12/201304:30GlobeNewswireMedigene erhält weiteres europäisches Patent für Autoimmun-Medikamentenkandidaten RhuDex®NYSE:MDGMeridian Gold
11/12/201304:30GlobeNewswireMedigene announces Veregen® to be launched in the Czech Republic, Poland, Hungary, and SlovakiaNYSE:MDGMeridian Gold
11/12/201304:30GlobeNewswireMedigene kündigt Markteinführung von Veregen® in Tschechien, Polen, Ungarn und der Slowakei anNYSE:MDGMeridian Gold
05/12/201304:31GlobeNewswireTaurus becomes new marketing partner for Medigene's drug Veregen® in GermanyNYSE:MDGMeridian Gold
05/12/201304:30GlobeNewswireTaurus wird neuer Partner für Medigenes Medikament Veregen® in DeutschlandNYSE:MDGMeridian Gold
08/11/201304:30GlobeNewswireMedigene reports financial results for the first nine months of 2013NYSE:MDGMeridian Gold
08/11/201304:30GlobeNewswireMedigene veröffentlicht 9-Monats-Finanzbericht 2013NYSE:MDGMeridian Gold
01/10/201302:30GlobeNewswireMedigene announces market launch of Veregen® in TaiwanNYSE:MDGMeridian Gold
01/10/201302:30GlobeNewswireMedigene gibt Markteinführung von Veregen® in Taiwan bekanntNYSE:MDGMeridian Gold
10/09/201302:30GlobeNewswireMedigene's Drug Veregen® receives market approval in CanadaNYSE:MDGMeridian Gold
10/09/201302:30GlobeNewswireMedigenes Medikament Veregen® erhält Zulassung für KanadaNYSE:MDGMeridian Gold
21/08/201302:31GlobeNewswireMedigene to implement 4:1 share capital reduction effective 3 September 2013NYSE:MDGMeridian Gold
21/08/201302:30GlobeNewswireMedigene vollzieht angekündigte 4:1 Kapitalherabsetzung mit Wirkung zum 3. September 2013NYSE:MDGMeridian Gold
09/08/201302:30GlobeNewswireMedigene veröffentlicht 6-Monats-Finanzbericht 2013NYSE:MDGMeridian Gold
09/08/201302:30GlobeNewswireMedigene reports financial results for the first 6 months of 2013NYSE:MDGMeridian Gold
06/08/201302:31GlobeNewswireMedigene and Difa Cooper enter into agreement for the commercialization of Veregen® in ItalyNYSE:MDGMeridian Gold
06/08/201302:30GlobeNewswireMedigene und Difa Cooper vereinbaren Partnerschaft zur Vermarktung von Veregen® in ItalienNYSE:MDGMeridian Gold
29/07/201302:30GlobeNewswireMedigene AG: Markteinführung von Veregen® in Niederlanden gestartetNYSE:MDGMeridian Gold
29/07/201302:30GlobeNewswireMedigene AG: Market launch of Veregen® in the Netherlands startedNYSE:MDGMeridian Gold
17/07/201310:58GlobeNewswireMedigene Reports Outcome of Annual General MeetingNYSE:MDGMeridian Gold
17/07/201310:58GlobeNewswireMedigene berichtet über Ergebnisse der HauptversammlungNYSE:MDGMeridian Gold
05/06/201303:03GlobeNewswireMedigene plant Herabsetzung des Grundkapitals sowie Verkleinerung und Neuwahl des AufsichtsratsNYSE:MDGMeridian Gold
05/06/201303:03GlobeNewswireMedigene announces capital reduction and nomination of new members to a reduced Supervisory BoardNYSE:MDGMeridian Gold
04/06/201303:00GlobeNewswireMedigene's drug Veregen® receives market authorization notification in TaiwanNYSE:MDGMeridian Gold
04/06/201303:00GlobeNewswireMedigenes Medikament Veregen® erhält Zulassung für TaiwanNYSE:MDGMeridian Gold
 Apresentando as notícias mais relevantes sobre:NYSE:MDG

Seu Histórico Recente

Delayed Upgrade Clock